Company news
Eom Pharmaceutical Holdings Inc. (OTC:IMUC) news
Eom Pharmaceutical Holdings Inc. news releases on 6ix. Latest, May 27, 2026: EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial…
Press releases & updates
EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients
May 27, 2026
EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147
January 7, 2026
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
November 6, 2023
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
September 5, 2023
Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
October 3, 2022
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
December 2, 2021